program logo/macu/on light

Understanding Dry AMD and Geographic Atrophy (September 2022)

  • Chats
Published on:


David Liao

David S. Liao, MD

Retina-Vitreous Associates Medical Group

Wednesday, September 28, 2022
1:00 pm EST (please adjust for your time zone)

Understanding Dry AMD and Geographic Atrophy.” The event featured Dr. David S. Liao, a board-certified ophthalmologist at the Retina-Vitreous Associates Medical Group, who specializes in the medical and surgical treatment of diseases of the retina and vitreous. The hosts discussed a proposed and promising pharmaceutical under investigation for geographic atrophy (GA) using a targeted C3 therapy. There was also discussion about other possible treatment for Age-related Macular Degeneration (AMD) and GA, clinical research, how long eye disease may take to progress, and regular provider visits with optometrists and ophthalmologists.

This program is supported in part by educational grants from NovartisGenentech, Delta Gamma Foundation, Apellis, and Alexion.

Chat Sponsor logos: Novartis, Genentech, Delta Gamma Foundation, Apellis, and Alexion.

Don't miss out.

Receive macular degeneration breakthrough news, research updates, and inspiring stories.